Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. GINO BIOW
  6. News
  7. Summary
    DNA   US37611X1000

GINO BIOW

(DNA)
SummaryChartsNewsRatingsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Soaring Eagle Acquisition Corp. Announces Board and Committee Appointments

02/26/2021 | 04:06pm EDT

Soaring Eagle Acquisition Corp. announced that on February 23, 2021, in connection with the IPO, Scott M Delman, Joshua Kazam, Isaac Lee, Timothy Leiweke, Dennis A. Miller and Laurence E. Paul were appointed to the board of directors of the Company (the “Board”). Messrs. Delman, Kazam, Lee, Leiweke, Miller and Paul are independent directors. Effective February 23, 2021, Messrs. Delman, Miller and Paul were appointed to the Board’s Audit Committee and Compensation Committee, with Mr. Delman serving as chair of the Audit Committee and Dr. Paul serving as chair of the Compensation Committee. Following the appointment of Messrs. Delman, Kazam, Lee, Leiweke, Miller and Paul, the Board is comprised of the following three classes: the term of office of the first class of directors, Class I, consists of Messrs. Delman, Kazam and Lee and will expire at the Company’s first annual meeting of shareholders; the term of office of the second class of directors, Class II, consists of Messrs. Leiweke, Miller and Paul and will expire at the Company’s second annual meeting of shareholders; and the term of office of the third class of directors, Class III, consists of Harry E. Sloan and will expire at the Company’s third annual meeting of shareholders.


ę S&P Capital IQ 2021
All news about GINO BIOW
10/15SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ginkg..
PR
10/14GINKGO BIOWORKS : Shares Climb in Slack Trading
MT
10/13GINKGO BIOWORKS : Raymond James Starts Ginkgo Bioworks Holdings at Outperform with $14.50 ..
MT
10/12GINKGO BIOWORKS : William Blair Starts Ginkgo Bioworks Holdings at Outperform
MT
10/08GINKGO INVESTIGATION ALERT : Kessler Topaz Meltzer & Check, LLP is Investigating Securitie..
PR
10/08INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Gin..
PR
10/07GINKGO ALERT : Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc...
BU
10/07DNA BREAKING NEWS : ROSEN, LEADING INVESTOR COUNSEL, Encourages Ginkgo Bioworks Holdings, ..
PR
10/07SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ginkg..
PR
10/07DNA INVESTIGATION ALERT : á Kessler Topaz Meltzer & Check, LLP is Investigating Securities..
BU
More news
Analyst Recommendations on GINO BIOW
More recommendations
Chart GINO BIOW
Duration : Period :
GINO BIOW Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GINO BIOW
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Managers and Directors
Jason Kelly Chief Executive Officer & Director
Reshma Shetty President, Chief Operating Officer & Director
Mark Dmytruk Chief Financial Officer
Arie S. Belldegrun Independent Director
Marijn E. Dekkers Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GINO BIOW0.00%23 313
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414